Sodium acetate increases the productivity of HEK293 cells expressing the ECD-Her1 protein in batch cultures: experimental results and metabolic flux analysis

Front Bioeng Biotechnol. 2024 Apr 10:12:1335898. doi: 10.3389/fbioe.2024.1335898. eCollection 2024.

Abstract

Human Embryonic Kidney cells (HEK293) are a popular host for recombinant protein expression and production in the biotechnological industry. This has driven within both, the scientific and the engineering communities, the search for strategies to increase their protein productivity. The present work is inserted into this search exploring the impact of adding sodium acetate (NaAc) into a batch culture of HEK293 cells. We monitored, as a function of time, the cell density, many external metabolites, and the supernatant concentration of the heterologous extra-cellular domain ECD-Her1 protein, a protein used to produce a candidate prostate cancer vaccine. We observed that by adding different concentrations of NaAc (0, 4, 6 and 8 mM), the production of ECD-Her1 protein increases consistently with increasing concentration, whereas the carrying capacity of the medium decreases. To understand these results we exploited a combination of experimental and computational techniques. Metabolic Flux Analysis (MFA) was used to infer intracellular metabolic fluxes from the concentration of external metabolites. Moreover, we measured independently the extracellular acidification rate and oxygen consumption rate of the cells. Both approaches support the idea that the addition of NaAc to the culture has a significant impact on the metabolism of the HEK293 cells and that, if properly tuned, enhances the productivity of the heterologous ECD-Her1 protein.

Keywords: HEK293 cell line; heterologous protein; metabolic flux analysis; metabolomics; sodium acetate.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. We have received funding from the European Union Horizon 2020 Research and Innovation Program MSCA-RISE-2016 under grant agreement No. 734439 INFERNET. Also, we received financial support from the European REA, Marie Skłodowska-Curie Actions, grant agreement No. 101131463 (SIMBAD).